The Regional Centre for Biotechnology (RCB) has announced a recruitment drive for the position of Project Research Scientist I (Non-Medical) for the year 2026. This role is specifically tied to a research project focused on the repurposing and validation of the FDA-approved UGCG inhibitor 'Eliglustat' for cancer immunotherapy. The institute is seeking a highly qualified researcher to contribute to this critical scientific endeavor.
Joining this project offers a unique opportunity to work on cutting-edge cancer research at a premier biotechnology institution. The role provides a competitive monthly fellowship and the chance to contribute to significant advancements in medical science, enhancing your professional profile in the research community.